⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 24, 2026

Advantan 0,1 % - Salbe 0,1 % (Salbe)

📷 Wikipedia: Methylprednisolone aceponate · Source
Advantan 0,1 % - Salbe 0,1 % (Salbe)
📷 Wikipedia: Methylprednisolone aceponate · Source
Advantan 0.1% ointment is temporarily unavailable in the 300g pack size due to manufacturing delays. The 30g and 15g tube sizes remain available.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 79 days ago.
📈 Timeline
30 days in total
June 25, 2026 July 25, 2026

What is this? This is a skin cream called Advantan. It contains a mild steroid to help with rashes or eczema.

What's happening? There is a short supply of the 300-gram tube size. Other sizes are still available.

Does this affect me? If you use the large 300-gram tube, you may have trouble finding it.

What should I do? Ask your pharmacist if another size would work for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
METHYLPREDNISOLON ACEPONAT
Agency-published detail

ATC: D07AC14 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: LEO PHARMA A/S, Industriparken 55, 2750 Ballerup, Kingdom of Denmark · Affected packs: 300 g Schachtel, Tiegel (NE) [eingeschränkt verfügbar, since 2026-06-24, resupply 2026-08-03] · 30 g Schachtel, Tube [verfügbar] · 15 g Schachtel, Tube [verfügbar]

First published
June 24, 2026
Last refreshed by us
1 month ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 1 day ago

Advantan 0,1 % - Creme 0,1 % (Creme)

ATC: D07AC14 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: LEO PHARMA A/S, Industriparken 55, 2750 Ballerup, Kingdom of Denmark · Affected packs: 300 g Schachtel,...

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Advantan 0,1 % - Salbe 0,1 % (Salbe). Advantan 0.1% ointment is temporarily unavailable in the 300g pack size due to manufacturing delays. The 30g and 15g tube sizes remain available.
▸ When was this alert issued?
This alert was issued on June 24, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.